Anti-amiodarone antibodies: Detection and relationship to the development of side effects

The American Journal of Medicine

Volumn 85, Issue 2, 1988, Pages 197-202

  Pichler, Werner J ^a   Schindler, Liesl ^a   Stäubli, Max ^a   Stadler, Beda M ^a   Weck, Alain L de ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

ADVERSE DRUG REACTION; CLINICAL ARTICLE; HUMAN; PRIORITY JOURNAL; THYROID DISEASE;

ADULT; AGED; AMIODARONE; ANTIBODIES; ARRHYTHMIA; FEMALE; HUMAN; IMMUNOASSAY; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; THYROID DISEASES;

EID: 0023759127     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(88)80342-5     Document Type: Article

References (38)

1. Serious adverse effects of amiodarone
2. Side effects of longterm amiodarone therapy
3. Thésaurismose corneism dû à la Cordarone
4. Amiodaronepigmentierung. Eine seltene aber typische Medikamentennebenwirkung
5. Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxine and thyrotropin
6. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy
7. Amiodarone-induced hypothyroidism
8. Amiodarone, thyroid hormone indexes, and altered thyroid function: longterm effects in patients with cardiac arrhythmias
9. Amiodarone (Cordarone) and Schilddruse
10. Thyroid dysfunction during chronic amiodarone therapy
11. Amiodarone pulmonary toxicity: chemical and subchemical features
12. Amiodarone pulmonary toxicity
13. Prospective evaluation of amiodarone pulmonary toxicity
14. Amiodarone-induced hypersensitivity pneumonitis. Evidence of an immunological cell mediated mechanism
15. Low dose steroid therapy for prophylaxis of amiodarone-induced pulmonary infiltrates
16. Neuropathy and fatal hepatitis in a patient receiving amiodarone
17. Frequent neurological toxicity associated with amiodarone therapy
18. Neuropathy during chronic amiodarone treatment
19. Amiodarone neuropathy
20. Peripheral neuropathy induced by amiodarone chlorhydrate
21. Probable early acute hepatitis with parenteral amiodarone
22. Amiodarone-associated phospholipidosis and fibrosis of the liver
23. Amiodarone hepatotoxicity
24. Chronic liver disease after low daily doses of amiodarone
25. Amiodarone-induced vasculitis and polyserositis
26. Cutaneous vasculitis associated with amiodarone therapy
27. Noninfectious epididymitis associated with amiodarone therapy (letter)
28. Amiodaroneinduced thrombocytopenia
29. Side effects and complications of amiodarone therapy
30. Electron-microscopic demonstration of lysosomal inclusion bodies in lung, liver, lymph nodes and blood leukocytes of patients with amiodarone pulmonary toxicity
31. Amiodarone therapy and autoimmune thyroid disease: increase in a new monoclonal antibody defined T-cell subset
32. Application of the dotimmunobinding assay to allergy diagnosis
33. Dot immunobinding assay with monoclonal anti-IgE antibodies for the detection and quantitation of human IgE
34. Serum concentration of amiodarone during long term therapy. Relation to dose, efficacy and toxicity
35. Immunelectrophoretic “tailing” of albumin line due to albumin-IgG-antibody complexes: a side effect of nitrofurantoin treatment
36. Morphologic and functional substrate of thyrotoxicosis caused by nodular goiters
37. Amiodarone and thyroid function: clinical applications during antiarrhythmic therapy
38. T cell reactivity to penicillin: phenotypic analysis of in vitro activated cell subsets